FOLD Stock Could See a Surge Soon, Says Signal

Despite its recent rebound, short sellers are still piling on

by Lillian Currens

Published on Apr 15, 2019 at 3:36 PM

Pharmaceutical name Amicus Therapeutics, Inc. (NASDAQ:FOLD) has put on quite the performance this year -- outperforming the broader S&P 500 Index (SPX) by 16% during the past two months. The security is up almost 40% year-to-date, staging an impressive rally off its 18-month lows from late December. What's more, FOLD just hit a year-to-date high of $14.62 last week.

While a familiar area of resistance at the $14.50 level has kept a tight lid on Amicus stock, it sounded a bullish signal that could send the equity back up the charts. Specifically, FOLD is trading within one standard deviation of its 40-day moving average after a lengthy stretch above it.

The six other times this signal has flashed in the past three years, the stock was positive one week later 67% of the time, and averaged a 7.14% gain. From where it currently sits at $13.54, a similar move would send the security right back below its 2019 high, at $14.51. 

FOLD Chart Apr 15

Analysts have been resoundingly enthusiastic on the equity, with nine "strong buy" ratings on the table, and only one "hold." Plus, the consensus 12-month target price of $18.80 sits in territory not seen by FOLD since its 2015 record highs, and represents a 40.1% premium to current levels. 

Short sellers have continued to pile on their bearish bets, despite FOLD's recent spike. Short interest shot up 6.4% in the last two reporting periods. The 21.13 million shares sold short accounts for a solid 12.8% of the stock's available float. At the equity's average trading volume, it would take over eight days for traders to cover these pessimistic positions, which could lend itself to a short squeeze.

Traders might want to consider betting on Amicus Therapeutics' next leg up with options. FOLD's Schaeffer's Volatility Index (SVI) of 53% stands higher than just 17% of all other readings from the past year. This means that short-term options are relatively cheap right now. 


START YOUR SATURDAY SMARTER.


The best of Schaeffer's market analysis in a 5-minute weekly read.


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


16-Hour "Jump Trades" Unlock New Profit Potential
Click to continue to advertiser's site.
Why Dermira, Menlo Therapeutics are Red-Hot Today
The broader stock market is much lower this afternoon, though
Banks, Blue Chips Kick Off Earnings Season
Dow earnings are expected to come in droves again next week
16-Hour "Jump Trades" Unlock New Profit Potential
Click to continue to advertiser's site.